Skip to main content
Log in

HPV vaccination shows limited cost effectiveness in Austria

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Zechmeister I, Freiesleben De Blasio B, Garnett G, Neilson AR, Seibert U.Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria. Vaccine 27: 5133-5141, No. 37, 13 Aug 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

HPV vaccination shows limited cost effectiveness in Austria. Pharmacoecon. Outcomes News 587, 8 (2009). https://doi.org/10.2165/00151234-200905870-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905870-00023

Keywords

Navigation